All Transactions
Buy Side Advisory
Strata Partners advises Pharmaron on the acquisition of Absorption Systems
Counterparty
Absorption Systems
Sector
Life Sciences CRO
Date
2020
Amount
up to US$137.5m


Strata Partners is delighted to announce that it acted as exclusive corporate finance adviser to Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”), a fully integrated contract research and manufacturing organization offering laboratory, CMC and clinical development services for the life science industry, on its acquisition of 100% of the equity of Absorption Systems for up to US$137.5 million in cash.
Interested in working with us?
Our partners are available to discuss potential mandates across all sectors and transaction types.
Contact Us



